Abstract
The advent of stem cells into the public arena in 1998 raised hopes for the treatment of a host of debilitating diseases affecting many organs and tissues of the body. The stem cells on which most attention was paid were embryonic stem cells, on account of their enormous biological potential. However, their derivation from human embryos raised major ethical qualms, involving as it does the destruction of embryos. The hype accompanying stem cells has had repercussions ranging from medical tourism to scientific fraud. The emergence in 2006 of induced pluripotent stem cells added to the clamor surrounding stem cells, since these appeared to surmount the ethical problems through bypassing an origin in embryos. These stem cells are obtained by reprogramming adult body cells so that they revert to a pluripotent state and appear to have a potential akin to that of embryonic stem cells. Embryos from which embryonic stem cells are derived may be nonviable, surplus embryos from IVF programs, embryos produced for research purposes, embryos created using somatic cell nuclear transfer, and human admixed embryos. Policy and regulatory frameworks governing the production of embryonic stem cells fall into four dominant categories, each with differing underlying ethical strictures and also with substantial scientific and clinical repercussions. The comparative status of embryonic and induced pluripotent stem cells is assessed both scientifically and ethically.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bridge, S. (2013). Induced pluripotent stem cells: An alternative to embryonic stem cells? Asian Bioethics Review, 5, 25–39.
Bush, G. W. (2006). On stem cell research. In M. Ruse & C. A. Pynes (Eds.), The stem cell controversy: Debating the issues (2nd ed.). Amherst: Prometheus Books.
Cyranoski, D. (2004). Korea’s stem-cell stars dogged by suspicion of ethical breach. Nature, 429, 3.
Cyranoski, D. (2014). Cloning comeback. Nature, 505, 468–471.
European Science Foundation. (2013). Human stem cell research and regenerative medicine: Focus on European policy and scientific contributions. Strasbourg: European Science Foundation.
Francis, D. P., et al. (2013). Autologous bone marrow-derived stem cell therapy in heart disease: Discrepancies and contradictions. International Journal of Cardiology, 168, 3381–3401.
Hinxton Group: An International Consortium on Stem Cells, Ethics and Law. (2006). World stem cell policies http://www.hinxtongroup.org/wp_ao_map.html. Accessed 28 May 2014.
Human Fertilisation Embryology Authority (HFEA). (2007). Hybrids and Chimeras: A report on the findings of the consultation. London: HFEA.
Jones, D. G., & Whitaker, M. I. (2009). Speaking for the dead: The human body in biology and medicine (2nd ed.). Farnham: Ashgate Publishing.
Jonlin, E. C. (2014). Differing standards fir the NIH stem cell registry and FDA approval render most federally funded hESC lines unsuitable for clinical use. Cell Stem Cell, 14, 139–140.
Solbakk, J. H. (2008). The ethics of stem cell research: Can the disagreements be resolved? Journal of Medical Ethics, 34, 831–832.
Tachibana, M., et al. (2013). Human embryonic stem cells derived by somatic cell nuclear transfer. Cell, 153, 1228–1238.
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
Thomson, J. A., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147.
Towns, C., & Jones, D. G. (2004). Stem cells, embryos and the environment: A context for both science and ethics. Journal of Medical Ethics, 30, 410–413.
Towns, C., & Jones, D. G. (2006). Stem cells: Policy and ethics. In M. Ruse & C. A. Pynes (Eds.), The stem cell controversy: Debating the issues (2nd ed., pp. 329–341). Amherst: New York, Prometheus Books.
Further Readings
Cohen, C. B. (2007). Renewing the stuff of life: Stem cells, ethics and public policy. New York: Oxford University Press.
President’s Council on Bioethics. (2007). Advancing stem cell science without destroying human life, Domestic Policy Council, The White House.
Ruse, M., & Pynes, C. A. (Eds.). (2006). The stem cell controversy: Debating the issues (2nd ed.). Amherst: Prometheus Books.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Jones, D.G. (2016). Stem Cells: Embryonic. In: ten Have, H. (eds) Encyclopedia of Global Bioethics. Springer, Cham. https://doi.org/10.1007/978-3-319-09483-0_401
Download citation
DOI: https://doi.org/10.1007/978-3-319-09483-0_401
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09482-3
Online ISBN: 978-3-319-09483-0
eBook Packages: Religion and PhilosophyReference Module Humanities and Social SciencesReference Module Humanities